Access Statistics for Alastair Gray

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Care in the community: a study of services and costs in six districts 0 0 0 6 0 2 4 73
Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe 0 0 1 24 3 4 5 127
Cost of poor adherence to anti-hypertensive therapy in five European countries 0 0 0 0 1 5 10 49
Liability, insurance and defensive medicine: new evidence 0 0 1 136 1 4 6 549
Reducing Harm to Patients in the National Health Service. Will the Government’s Compensation Proposals Help? 0 0 0 3 5 5 5 29
Staff turnover in the NHS: a preliminary economic analysis 0 0 2 89 2 5 8 438
Wellbeing Over 50: A Capabilities Approach 0 0 0 0 6 9 12 92
Total Working Papers 0 0 4 258 18 34 50 1,357
1 registered items for which data could not be found

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Systematic Review and Critical Assessment of Health State Utilities 0 0 0 8 6 14 14 107
A Systematic Review and Critical Assessment of Health State Utilities 0 0 0 0 3 4 5 7
A longitudinal study of the effects of age and time to death on hospital costs 1 1 1 197 3 7 8 492
A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research Centres 0 0 0 0 3 6 7 11
Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data 0 0 0 0 3 4 6 11
Ageing and health‐care expenditure: the red herring argument revisited 0 0 3 242 5 7 15 689
An exercise on the feasibility of carrying out secondary economic analyses 0 0 0 0 1 1 3 5
Centre‐specific or average unit costs in multi‐centre studies? Some theory and simulation 0 0 0 4 3 7 8 71
Changing experience of adverse medical events in the National Health Service: Comparison of two population surveys in 2001 and 2013 0 0 0 2 1 3 5 19
Cost of poor adherence to anti-hypertensive therapy in five European countries 0 0 0 10 6 6 7 71
Cost-Effectiveness of Pre-Referral Antimalarial, Antibacterial, and Combined Rectal Formulations for Severe Febrile Illness 0 0 0 0 3 4 4 7
Current UK Practices on Health Economics Analysis Plans (HEAPs): Are We Using Heaps of Them? 0 0 0 3 1 3 4 17
Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions 0 0 0 1 2 4 7 11
Economic evaluation of healthcare interventions: old and new directions 0 0 1 55 0 1 10 150
Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62) 0 0 0 13 2 5 7 36
Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping 0 0 0 0 2 9 10 11
Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge 0 0 0 2 6 6 8 22
Forecasting the impact of demographic change: the case of the British National Health Service 0 0 0 10 3 4 5 41
From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap 0 0 0 19 4 4 7 130
Health Economics: A Review Article 0 0 0 0 5 5 5 241
Improving Clinical Reality in Chronic Obstructive Pulmonary Disease Economic Modelling 0 0 0 1 3 5 7 38
Labour turnover in the British National Health Service: a local labour market analysis 0 0 0 14 0 2 2 76
Liability, insurance and medical practice 0 0 1 60 3 4 6 224
Life Expectancy in Individuals With Type 2 Diabetes: Implications for Annuities 0 0 0 0 2 4 6 10
Mapping from the Parkinson’s Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L 0 0 0 0 3 6 9 11
Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome 0 0 1 3 2 5 8 21
Obesity as Market Failure: Could a ‘Deliberative Economy’ Overcome the Problems of Paternalism? 0 0 1 165 5 9 12 750
Operationalising the capability approach for outcome measurement in mental health research 1 2 2 24 2 4 10 111
PROFESSOR GAVIN MOONEY 1943–2012 0 0 0 0 2 3 5 43
Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis 0 0 0 1 3 4 5 15
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK 0 0 1 1 3 3 4 4
Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement 0 0 0 0 1 2 4 9
Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement 0 0 0 1 2 2 2 31
Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement 0 0 0 0 1 2 2 15
Professional Autonomy and the Cost of Legal Aid 0 0 0 0 3 5 8 429
Programme budgeting in the health sector 0 0 0 12 1 2 2 63
Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis 0 0 0 0 1 2 2 5
Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country 0 0 0 0 1 2 2 19
Resource Use and Costs Associated with Coeliac Disease before and after Diagnosis in 3,646 Cases: Results of a UK Primary Care Database Analysis 0 0 0 0 0 2 5 7
Risk attitudes of people with ‘manageable’ chronic disease: An analysis under prospect theory 0 0 0 2 2 3 9 39
Standard fees for legal aid: an empirical analysis of incentives and contracts 0 0 0 29 0 2 2 109
THE EFFECT OF DIABETES COMPLICATIONS ON HEALTH‐RELATED QUALITY OF LIFE: THE IMPORTANCE OF LONGITUDINAL DATA TO ADDRESS PATIENT HETEROGENEITY 0 0 0 2 0 3 4 41
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood 0 0 0 0 0 1 2 17
The Economics of Clinical Negligence Reform in England 0 0 0 45 2 3 9 256
The Impact of Risk Management Standards on Patient Safety: The Determinants of MRSA Infections in Acute NHS Hospitals, 2001–08 0 0 0 7 4 6 7 53
The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration 0 0 0 0 2 4 5 16
The Production of Dental Care in the British National Health Service 0 0 0 0 1 3 5 118
The Reform of Legal Aid 0 0 0 0 3 4 5 140
The Use and Cost of HIV Service Provision in England in 1996 0 0 0 7 2 5 9 284
The costs of nursing turnover: evidence from the British National Health Service 0 0 0 40 2 2 4 162
The reform of Legal Aid in England and Wales 0 0 1 198 2 3 6 755
The valuation of prenatal life in economic evaluations of perinatal interventions 0 0 1 11 0 3 7 89
Wellbeing over 50 0 0 0 11 4 7 8 57
Total Journal Articles 2 3 13 1,200 124 221 328 6,166
1 registered items for which data could not be found

Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Applied Methods of Cost-effectiveness Analysis in Healthcare 0 0 0 0 14 27 107 1,977
Total Books 0 0 0 0 14 27 107 1,977

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2026-02-12